Open AccessThe Role of Multimodality Imaging in Cardiac Sarcoidosis
Author(s) -
Noriko OyamaManabe,
Osamu Manabe,
Tadao Aikawa,
Satonori Tsuneta
Publication year - 2021
Publication title -
korean circulation journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.809
H-Index - 29
eISSN - 1738-5555
pISSN - 1738-5520
DOI - 10.4070/kcj.2021.0104
Subject(s) - medicine , cardiac sarcoidosis , positron emission tomography , sarcoidosis , magnetic resonance imaging , heart failure , cardiac magnetic resonance imaging , cardiac imaging , radiology , cardiac magnetic resonance , fluorodeoxyglucose , cardiology , etiology
The etiology and the progression of sarcoidosis remain unknown. However, cardiac sarcoidosis (CS) is significantly associated with a poor prognosis due to the associated congestive heart failure, arrhythmias (such as an advanced atrioventricular block), and ventricular tachyarrhythmia. Novel imaging modalities are now available to detect CS lesions secondary to active inflammation, granuloma formation, and fibrotic changes. 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and cardiac magnetic resonance imaging (CMR) play essential roles in diagnosing and monitoring patients with confirmed or suspected CS. The following focused review will highlight the emerging role of non-invasive cardiac imaging techniques, including FDG PET/CT and CMR.